28 related articles for article (PubMed ID: 34636141)
21. The success rate of interphase fluorescence in situ hybridization in plasma cell disorders can be improved using unconventional sources of plasma cells.
Panakkal V; Rana S; Rathore S; Anshu A; Balakrishnan A; Singh C; Jandial A; Sachdeva MUS; Varma N; Lad D; Malhotra P; Sreedharanunni S
Int J Lab Hematol; 2022 Feb; 44(1):157-162. PubMed ID: 34636141
[TBL] [Abstract][Full Text] [Related]
22. Assessing genome-wide copy number aberrations and copy-neutral loss-of-heterozygosity as best practice: An evidence-based review from the Cancer Genomics Consortium working group for plasma cell disorders.
Pugh TJ; Fink JM; Lu X; Mathew S; Murata-Collins J; Willem P; Fang M;
Cancer Genet; 2018 Dec; 228-229():184-196. PubMed ID: 30393007
[TBL] [Abstract][Full Text] [Related]
23. Interphase cytogenetics in pathology: principles, methods, and applications of fluorescence in situ hybridization (FISH).
Werner M; Wilkens L; Aubele M; Nolte M; Zitzelsberger H; Komminoth P
Histochem Cell Biol; 1997; 108(4-5):381-90. PubMed ID: 9387931
[TBL] [Abstract][Full Text] [Related]
24. Detection of numerical aberrations in hematologic neoplasias by fluorescence in situ hybridization.
Cuneo A; Bigoni R; Roberti MG; Bardi A; Balsamo R; Piva N; Castoldi G
Haematologica; 1997; 82(1):85-90. PubMed ID: 9107092
[TBL] [Abstract][Full Text] [Related]
25. Flow Cytometric Analysis of Mechanically Disaggregated Bone Marrow Trephine Biopsies.
Wheeler M; White G; Brockie S; Dickson M; Weinkove R
Cytometry B Clin Cytom; 2018 Nov; 94(6):935-940. PubMed ID: 30350400
[TBL] [Abstract][Full Text] [Related]
26. Making sense of plasma cell heterogeneity.
Tarlinton DM; Ding Z; Tellier J; Nutt SL
Curr Opin Immunol; 2023 Apr; 81():102297. PubMed ID: 36889029
[TBL] [Abstract][Full Text] [Related]
27.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
28.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [New Search]
